Can a common blood thinner shield your brain from dementia?

NCT ID NCT03061006

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This completed study looked at whether two different blood thinners—dabigatran (Pradaxa) and warfarin (Coumadin)—could help prevent memory loss and dementia in people over 65 with atrial fibrillation (an irregular heartbeat). A total of 101 participants were randomly assigned to take one of the two medications and were followed for two years. Researchers tracked changes in thinking skills, dementia diagnoses, and brain scans to see if one drug offered better protection for the brain.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Dabigatran etexilate (Pradaxa) and warfarin (Coumadin)
What this could lead to
If successful, this study could show that choosing dabigatran over warfarin helps preserve memory and thinking skills in older adults with atrial fibrillation.
What could go wrong
This is a small, completed Phase 4 trial with only 101 participants, so results may not apply to everyone. The study compares two existing drugs, so no new treatment is being developed.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CEREBRAL ISCHEMIC EVENTS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Intermountain Heart Institute

    Murray, Utah, 84143, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.